Results 21 to 30 of about 88,904 (264)
Journal of Family Medicine and Primary Care, 2019 Upper gastrointestinal bleeding is one of the most commonly encountered emergencies in day-to-day practice. In the present retrospective study, the various causes of acute nonvariceal upper gastrointestinal bleeding (NVUGIB), its management modalities ...
Karma D Bhutia, Sangey C Lamtha
doaj +1 more source
Analysis of risk factors for delayed healing of peptic ulcer in patients with upper gastrointestinal bleeding [PDF]
Zhenduanxue lilun yu shijian, 2022 Objective: To investigate the risk factors for delayed healing of peptic ulcer in patients with upper gastrointestinal bleeding (UGIB), so as to provide evidences for clinical treatment. Methods: A total of consecutive 138 hospitalized patients with UGIB
DING Yanfei, XIN Xiaorong, ZHOU Yufen, XIE Ling, GU Leilei, WU Yunlin, CHEN Ping
doaj +1 more source
Acute upper gastrointestinal bleeding: A review
Surgery in Practice and Science, 2020 Gastrointestinal haemorrhage is potentially life threatening. Resuscitation, clinically diagnosing and treating the underlying problem are the principles of management. As most gastrointestinal haemorrhage cease spontaneously, there is greater importance
Elroy Patrick Weledji
doaj +1 more source
Guidelines for Nonvariceal Upper Gastrointestinal Bleeding
Gut and Liver, 2020 Nonvariceal upper gastrointestinal bleeding (NVUGIB) refers to bleeding that develops in the gastrointestinal tract proximal to the ligament of Treitz. NVUGIB requires hospitalization and is associated with significant morbidity and mortality.
Joon Sung Kim +12 more
doaj +3 more sources
Journal of Acute Disease, 2020 Acute upper gastrointestinal bleeding is one of the most common life-threatening diseases. Standardized diagnosis and treatment of acute upper gastrointestinal bleeding are of great importance for improving the prognosis. In 2015, the Emergency Physician
Jia-Yuan Dai +6 more
doaj +1 more source
Hepatology, EarlyView., 2022 A deleterious variant of FCHSD1 results in mTOR pathway overactivation and may cause porto‐sinusoidal vascular disorder (PSVD). The pedigree of the family demonstrated an autosomal dominant disease with variable expressivity. Whole‐genome sequencing and Sanger sequencing both validated the existence of the FCHSD1 variant and the heterozygosity of c ...
Jingxuan Shan +19 more
wiley +1 more source
Endoscopic Management of Nonvariceal Upper Gastrointestinal Bleeding
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2016 Acute nonvariceal upper gastrointestinal bleeding is a common medical emergency with associated morbidity and mortality. Patients with significant bleeding should be started on proton pump inhibitor infusion.
Jin Tae Jung
doaj +1 more source
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis
Hepatology, EarlyView., 2022 Diagram of the activation of the profibrotic and procontractile Janus kinase 2 (JAK2)/Ras homolog family member A/Rho‐kinase pathway and the inhibition of phosphorylated JAK2 by pacritinib to inhibit hepatic stellate cell activity. Abstract Background and Aims Janus kinase 2 (JAK2) signaling is increased in human and experimental liver fibrosis with ...
Sandra Torres +21 more
wiley +1 more source
Hepatology, EarlyView., 2022 Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study. Abstract Background and Aims Alagille syndrome (ALGS) is a multisystem disorder, characterized by cholestasis. Existing outcome data are largely derived from tertiary centers, and real‐world data are lacking.
Shannon M. Vandriel +93 more
wiley +1 more source
Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy
Hepatology, EarlyView., 2022 Serum bile acid levels predict outcomes in patients with biliary atresia who achieve normalized bilirubin levels after Kasai portoenterostomy. Abstract Background and Aims In biliary atresia, serum bilirubin is commonly used to predict outcomes after Kasai portoenterostomy (KP).
Sanjiv Harpavat +22 more
wiley +1 more source